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Abstract A novel human homologue (GCMB) of the Droso-
phila glial cells missing gene (dGCM) was isolated using RACE.
GCMB contained a gcm motif sequence and a nuclear targeting
sequence similar to that of dGCM and mouse GCMb. Homology
searches indicated that GCMB was located within chromosome
6p24.2. Transcripts of GCMB were detected by means of RT-
PCR in fetal brain, normal adult kidney, 3/3 medulloblastomas,
1/3 gliomas and 4/8 non-neuroepithelial tumor cell lines. Our
data suggest that humans have two homologues of gcm like mice
and that human gcm genes form a novel family which may
function not only during fetal development but also in the
postnatal or pathological stage.
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1. Introduction
The mammalian central nervous system (CNS) consists of
two di¡erent types of cells, neuron and glia, both of which
originate from common multipotential neural stem cells [1].
While several factors and mechanisms for neuronal di¡eren-
tiation of stem cells have been identi¢ed [2^7], the molecular
mechanisms controlling gliogenesis from them has not been
satisfactorily clari¢ed [8^10].
A new gene, glial cells missing (gcm), was recently isolated
from Drosophila melanogaster [11^13]. In Drosophila, the glial
precursors which express gcm (dgcm, GenBank accession
numbers U34039, D64040, U81164) in a speci¢c stage of early
development di¡erentiate into glia and the dgcm encodes a
504-amino acid protein (dGCM). The N-terminal region of
dGCM which has a DNA-binding activity is named the gcm
motif. Drosophila GCM thus was thought to be a novel tran-
scription regulatory factor which promotes gliogenesis [14,15].
Since the isolation of dgcm, several mammalian homo-
logues of gcm have been identi¢ed in mice from not only
brain (mgcmb: GenBank accession number D88611) but
also non-neuroepithelial sources (mgcma/1: GenBank acces-
sion number D88612, U59876) [14,16]. All these gcm proteins
(GCMs) have a common, highly conserved gcm motif in the
N-terminal portion and the relevant ¢ndings strongly suggest
that the gcm motif is evolutionarily well conserved and that
gcms form a novel gene family of DNA-binding proteins
[14,17].
In humans, a single gcm homologue has so far been isolated
from placenta (human gcma; hgcma, GenBank accession
number D88613) [14] but not from human brain. For the
study reported here, we succeeded in isolating a novel human
homologue of gcm (human gcmb; Human Gene Nomencla-
ture Committee-approved symbol, GCMB) from human brain
cDNA library by using the rapid ampli¢cation of cDNA ends
(RACE) method and examined the character and expression
of this homologue in human.
2. Materials and methods
2.1. Cloning of the GCMB cDNA
RACE was performed using 0.5 ng of human fetal brain Marathon-
Ready cDNA (Clontech, Palo Alto, CA, USA) as a template in com-
bination with Advantage cDNA Polymerase Mix (Clontech), accord-
ing to the manufacturer’s instruction. The ¢rst 3P-RACE used the
adapter primer (AP1, Clontech) and gene-speci¢c primer (GSP),
and the nested 3P-RACE used the nested adapter primer (AP2,
Clontech) and nested GSP (NGSP). The GSP sequences are as fol-
lows: GSP 5P-GCCATGCGCAATACCAACAACCACA-3P (¢rst 3P-
RACE); NGSP 5P-CATCCTCAAGAAGTCCTGCCTGGGT-3P
(nested 3P-RACE).
The RACE products were subcloned into a pGEM-T Easy vector
(Promega, Madison, WI, USA) and sequenced with several forward
and reverse primers using the ABI PRISM Big Dye Terminator Cycle
Sequencing Ready Reaction Kit (ABI, Foster City, CA, USA) in both
directions in conjunction with an ABI 310 genetic analyzer. We gen-
erated new GSPs from the partial sequence of GCMB. We started the
5P-RACE and repeated the 3P-RACE using the GSPs to identify the
full sequence of GCMB. The overlapping sequences of 5P- and 3P-
RACE products were thus combined and the full-length GCMB se-
quence was identi¢ed. The GCMB cDNA including a complete open
reading frame (ORF) was cloned from the same fetal brain cDNA by
using PCR.
Searches for homologue sequences were performed with the aid of
BLASTN, BLASTP and BLASTX algorithms and the protein motif
search was executed by using the PROSITE algorithm.
2.2. Southern blot analysis
Normal human genomic DNA was extracted from blood lympho-
cytes according to standard protocols [18]. For Southern blot analysis,
5 Wg aliquots of DNA digested with either EcoRI, BamHI, HindIII or
KpnI restriction enzymes, fractionated by electrophoresis in 0.8%
agarose gel (Seakem GTG, FMC, Rockland, ME, USA) and trans-
ferred onto a nylon membrane (Hybond N, Amersham Pharmacia
Biotech, Buckinghamshire, UK). A cDNA probe consisting of 417
nucleotides (nt) of the GCMB (nt 1428^1844) was generated by
PCR ampli¢cation and labeled with [K-32P]dCTP using a random
primer labeling method (Megaprime, Amersham Pharmacia Biotech).
The ¢lter was prehybridized for 1 h in ExpressHyb Hybridization
Solution (Clontech) at 60‡C and hybridized for 2 h with the GCMB
cDNA probe. Post-hybridization washes consisted of 3U15 min at
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room temperature with 2USSC/0.05% SDS and 2U20 min at 50‡C
with 0.1USSC/0.1% SDS. The ¢lter was exposed to X-ray ¢lm (Ko-
dak XAR-5, Rochester, NY, USA) overnight.
2.3. Cell lines and RNA extraction
Seven human neuroepithelial tumor cell lines were examined;
T98G, U251 and U-373MG originating from glioblastomas, Daoy,
D283 Med, and D341 Med originating from medulloblastomas and
KP-N-SILA-2B4 originating from a neuroblastoma [19]. Eight non-
neuroepithelial tumor cell lines were also investigated as controls;
HuH-6 [20] and Hep G2 from hepatocellular carcinomas, PANC-1
and BxPC-3 from pancreatic adenocarcinomas, Jurkat and K-562
from leukemias, NTera2/cl.D1 from a teratocarcinoma and 293T
from transformed embryonic kidney epithelial cells [21]. U251 was
purchased from Riken Cell Bank (Tsukuba, Japan), 293T was a gift
from Dr. M. Yamadori (Department of Medicine III, Osaka Univer-
sity Medical School, Osaka, Japan) and KP-N-SILA-2B4 was gifts
from Dr. T. Matsumura (Department of Pediatrics, Kyoto Prefectural
University of Medicine, Kyoto, Japan). HuH-6 was a gift from Dr. S.
Kishimoto (Department of Surgery II, Osaka University Medical
School, Osaka, Japan). The other cell lines were purchased from
American Type Culture Collection (Rockville, MD, USA).
Total RNA was extracted from the cultured cells in the logarithmic
phase with the acid guanidinium thiocyanate-phenol-chloroform ex-
traction procedure using TRIZOL reagent (Gibco-BRL, Gaithers-
burg, MD, USA) according to the manufacturer’s instructions.
2.4. Northern blot analysis
The ¢lters containing 2 Wg of poly(A) RNA from a variety of
human fetal and adult normal tissues were purchased from Clontech
(Human Multiple Tissue Northern Blot). For tumor cell lines, 10 Wg
of total RNA was denatured, fractionated by electrophoresis in 1.2%
agarose/formaldehyde gels and blotted onto nylon membrane ¢lters.
These ¢lters were prehybridized for 4 h in ExpressHyb at 68‡C and
hybridized for 24 h with the radiolabeled GCMB cDNA probe above
described. Post-hybridization washes consisted of 3U15 min at room
temperature with 2USSC/0.05% SDS and 2U20 min at 50‡C with
0.1USSC/0.1% SDS. The ¢lters were exposed to an X-ray ¢lm
(Kodak BioMax-MS) with double intensifying screens at 380‡C
for 3 days, 7 days and 14 days. To control loading of the RNA
extracts, the ¢lters were rehybridized with a 220-bp cDNA probe of
GAPDH after removal of the GCMB probe used, and exposed over-
night.
2.5. Detection of GCMB transcripts by RT-PCR
For RT-PCR analysis in normal human tissues, human ¢rst-strand
cDNA generated from poly(A) RNA was purchased from Clontech
(Multiple Tissue cDNA Panels). For tumor cells, cDNA was gener-
ated from 1 Wg of the total RNA using MMLV reverse transcriptase
(Gibco-BRL) and random hexamers [22,23]. Next, PCR was per-
formed using Takara Ex Taq polymerase (Takara, Otsu, Shiga, Ja-
pan) and GCMB-speci¢c primers (PF and PR) [22,23]. The primer
sequences were as follows: PF (forward) 5P-CACCTGGCGCACCT-
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Fig. 1. Nucleotide and deduced amino acid sequence of the GCMB. The highly conserved N-terminal region including the gcm motif is boxed.
The proposed nuclear targeting sequence is highlighted in black, PEST-like sequences are underlined and two homopolymeric stretches of pro-
line residues are denoted with a double underline.
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GTCCTTTTTTC-3P (nt 1^25 of GCMB), PR (reverse) 5P-GGCCAT-
TGTGGTTGTTGGTGTTGCG-3P (nt 271^295 of GCMB).
The PCR ampli¢cation program consisted of 30 or 40 cycles of a
denaturing step at 94‡C for 30 s and an annealing/extending step at
68‡C for 2 min.
The RT-PCR products were fractionated by electrophoresis in 2%
agarose gel (3:1 NuSieve GTG, FMC) and stained with ethidium
bromide. For the speci¢c detection of the ampli¢ed mRNA transcript
by RT-PCR, the fractionated products were transferred onto a nylon
membrane and hybridized with a Q-32P-end-labeled oligoprobe which
contained the 25-nt sequence of GCMB (nt 140^164 of GCMB) for 2 h
in ExpressHyb at 60‡C. Post-hybridization washes consisted of 3U15
min at room temperature with 2USSC/0.05% SDS and 2U20 min at
room temperature with 0.1USSC/0.1% SDS. The ¢lter was exposed to
X-ray ¢lm (Kodak XAR-5) overnight. To identify any non-speci¢c
ampli¢cation from genomic DNA, which could have been included in
the RNA extract, separate PCRs under the same conditions were
performed by using either the same RNA samples without reverse
transcription or genomic DNA as a template. For the control of
RNA loading and RT reaction, a 220-bp transcript of glyceraldehyde
3-phosphate dehydrogenase (GAPDH) was ampli¢ed in parallel for
all reactions as an internal standard for RNA.
3. Results
3.1. Cloning of the GCMB cDNA
Since the cDNA sequence of the mouse gcm motif is highly
conserved between mgcma/1 and mgcmb, we assumed that a
novel human gcm homologue (GCMB) should contain a gcm
motif sequence very similar to or completely matching hgcma.
We ¢rst generated two GSPs (GSP and NGSP) based on the
gcm motif sequence of hgcma for the 3P-RACE and nested 3P-
RACE of GCMB cDNA. An 841-bp fragment which con-
tained partial sequences of GCMB was isolated from the
nested 3P-RACE and used to generate eight more GSPs for
several 5P- and 3P-RACE procedures. Three independent
products were isolated from 5P-RACE and three from 3P-
RACE. Sequence analysis of these RACE products with over-
lapping regions revealed the full-length of the GCMB cDNA
sequence.
We then generated GCMB-speci¢c primers and cloned a
1639-bp product (nt 1^1639 of GCMB) including a complete
ORF by means of PCR from the same fetal cDNA. One of
the aforementioned 3P-RACE products was 1922 bp (nt 452^
2373 of GCMB). Since a 1188-nt sequence (nt 452^1639 of
GCMB) was common in these two products, full-length se-
quence of GCMB was judged to be derived from a single
mRNA.
3.2. Sequence analysis of the GCMB cDNA and deduced
protein
The isolated GCMB transcript is 2373 nt in length and has
FEBS 21394 13-1-99
Fig. 2. A: Comparison of GCMB, mouse GCMb (mGCMb), human GCMa (hGCMa) and Drosophila GCM (dGCM) sequences in the N-ter-
minal region of the proteins. The amino acid residues conserved through the four proteins are highlighted in black. Gaps are indicated by
dashes. B: Comparison of GCMB, mGCMb and hGCMa sequences in regions other than that of the gcm motif. Amino acid residues shared
by at least two products are highlighted in gray, the proposed nuclear targeting sequence is boxed and PEST-like sequences are underlined.
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an ORF which encodes a 506-amino acid protein. The AUG
codon at nt 73^75 which is likely to be the initiator methio-
nine is embedded in a poor Kozak consensus sequence (CAG
AUG C) similar to mgcmb (CAG AUG C), in contrast to
other gcms, which have a good Kozak consensus sequence,
such as dgcm (AAA AUG G), mgcm1 (ATC AUG G),
mgcma (ATC AUG G) and hgcma (ATC AUG G) [24].
The 3P-untranslated region (UTR) contained an AU-rich se-
quence (67.9%) which carries two mRNA instability motifs,
AUUUA [25], as does mgcmb (Fig. 1).
In the 172 amino acids of the N-terminal region of deduced
GCMB protein, the gcm motif has mostly preserved (Fig. 1)
and the N-terminal region revealed 86.0% homology to
mGCMb, 68.2% homology to hGCMa and 62.0% to dGCM
(Fig. 2A). In regions other than that of the gcm motif, GCMB
deduced protein was 59.3% similar to mGCMb but quite dif-
ferent from hGCMa (Fig. 2B). GCMB deduced protein has a
PEST-like sequences [26,27] like other GCMs and contains a
nuclear targeting sequence [28] and two homopolymeric
stretches of proline residues [29], both of which were absent
in hGCMa (Figs. 1 and 2B). The overall GCMB deduced
protein showed 68.4% similarity to mGCMb but only 46.5%
to hGCMa.
3.3. Analysis of the GCMB gene structure, deduced
chromosomal localization and homology searches
Southern blot analysis showed a single hybridization signal
for each human genomic DNA digested with a restriction
enzyme (Fig. 3). The size of the signal band was 4.6 kbp for
EcoRI, 6.2 kbp for BamHI, 4.8 kbp for HindIII and 5 kbp for
KpnI. From the results of homology searches of GenBank, we
determined that the P1 arti¢cial chromosome (PAC: PAC No.
dJ417M14, GenBank accession number AL024498) contained
1703 nucleotides corresponding to nt 655^2357 of the GCMB
with 99.8% homology. This PAC contains the 146-kbp human
genomic DNA sequence of chromosome 6p24.2 (Sanger Cen-
ter, http://www.sanger.ac.uk./HGP/Chr6/). The size of the
Southern hybridization signals for HindIII or KpnI coincided
with the restriction map of the PAC. These ¢ndings suggest
that the GCMB is most likely a unique gene and that GCMB
gene is located within the regions of 6p24.2.
We also identi¢ed 14 expressed sequence tags (ESTs) that
were almost completely consistent (over 98%) with the GCMB
sequence. All these ESTs were identi¢ed from human sporadic
parathyroid adenomas (GenBank accession numbers
AA724352, AA772631, AA782779, AA845533, AA845538,
AA860827, AA890229, AI022866, AI028145, AI034434,
AI051443, W16423, W19939 and W39214) which did not con-
tain any neuroepithelial tissues.
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Fig. 3. Southern blot analysis of GCMB gene using a 417-nucleotide
radiolabeled cDNA probe. Human genomic DNA digested with ei-
ther EcoRI (lane 1), BamHI (lane 2), HindIII (lane 3) or KpnI (lane
4) exhibited a single signal band. The size markers are indicated on
the right.
Fig. 4. Detection of GCMB transcripts in normal human tissues by
RT-PCR. Speci¢c products for GCMB (295 bp) and glyceraldehyde
3-phosphate dehydrogenase (GAPDH) (220 bp) used as controls in
agarose gel stained with ethidium bromide are shown. The size
marker (bp) is indicated by an arrow. Lane 1, heart; lane 2, brain;
lane 3, placenta; lane 4, lung; lane 5, liver; lane 6, skeletal muscle;
lane 7, kidney; lane 8, pancreas; lane 9, fetal brain; lane C, positive
control and lane M, marker.
Fig. 5. Detection of GCMB transcripts in human tumor cell lines
by RT-PCR. Speci¢c products for GCMB (295 bp) and glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH) (220 bp) used as con-
trols in agarose gel stained with ethidium bromide are shown. The
size marker (bp) is indicated by an arrow. (+) and (3) : PCR with
(+) and without (3) reverse transcription. A: The expression of
GCMB mRNA transcript in neuroepithelial tumor cell lines. Lane
1, U251; lane 2, T98G; lane 3, U-373MG; lane 4, Daoy; lane 5,
D283 Med; lane 6, D341 Med; lane 7, KP-N-SILA-2B4; lane C,
positive control and lane M, marker. B: The expression of GCMB
mRNA transcript in non-neuroepithelial tumor cell lines. Lane 1,
NTera2/cl.D1; lane 2, HuH-6; lane 3, Hep G2; lane 4, Jurkat; lane
5, K-562; lane 6, PANC-1, lane 7, BxPC-3; lane 8, 293T; lane 9,
human genomic DNA; lane C, positive control and lane M,
marker.
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3.4. Detection of GCMB transcripts in various normal human
tissues and tumor cell lines
Despite the use of radiolabeled cDNA probes with high
speci¢c activity, Northern blot analysis failed to reveal any
signi¢cant signals in either normal tissues or tumor cell lines
even with a 14-day exposure of the ¢lter (data not shown).
However, we managed to detect the expression of GCMB
transcripts by using RT-PCR. While no products from any
sources could be detected with 30-cycle ampli¢cation, a visible
295-bp product was identi¢ed in kidney and fetal brain with
40-cycle ampli¢cation (Fig. 4). The product was also detected
in one (T98G) of three gliomas, all three medulloblastomas
(Daoy, D283 Med, D341 Med) (Fig. 5A) and four (NTera2/
cl.D1, K-562, PANC-1 and 293T) of eight non-neuroepithelial
tumor cell lines (Fig. 5B). The product proved to be speci¢c
for GCMB as a result of hybridization analysis using a radio-
labeled oligonucleotide probe (data not shown). The PCR
products from RNA without reverse transcription or from
normal genomic DNA did not exhibit any detectable signals
as a result of hybridization analysis, indicating that the signal
was from the RNA extract and not from possibly contami-
nated genomic DNA in the extract.
4. Discussion
Drosophila gcm mRNA is transiently expressed in glial pre-
cursors and immature glial cells except for mesectodermal
midline glia during a short period of gliogenesis within the
CNS [11,12]. The cells which express dgcm di¡erentiate into
glia, which are marked by the expression of the glial homeo-
domain protein, repo [30,31]. In the absence of dgcm expres-
sion, presumptive glial cells di¡erentiate into neurons. An
ectopic overexpression of the dgcm forces many presumptive
neurons to be transformed into glia. These ¢ndings suggest
that GCM is required as a binary switch between neuronal
and glial determination in Drosophila [11,12]. Analysis of
dGCM revealed that dGCM had DNA-binding activity in
the gcm motif, and several dGCM-binding sites were found
in the promoter region of the repo gene [14,15]. Thus, dGCM
is likely to be a transcriptional activator which induces the
expression of repo, which encodes a downstream transcription
factor required for the terminal di¡erentiation of the Droso-
phila CNS glial cells [30,31]. These ¢ndings led many investi-
gators to explore the mammalian homologues of GCM to
reveal the regulatory mechanisms of gliogenesis in mammalian
nervous systems.
Since the isolation of dgcm, it has been found that Droso-
phila and mice have several gcm genes. Another Drosophila
gcm (dgcm2), whose function has not been analyzed yet, was
isolated from genomic DNA [14]. Two gcm analogues have
been identi¢ed in mice from adult brain (mgcmb) and placen-
ta (mgcma/1) [14,16]. The proteins (GCMs) deduced from
these gcms were highly similar in the N-terminal region and
the sequence was therefore named gcm motif [14]. The amino
acid sequence except for the gcm motif varied for each homo-
logue. It is therefore thought that gcms constitute a novel
gene family which contain the gcm motif as a common core
sequence.
We isolated a novel human homologue of gcm, GCMB, in
the present study. GCMB have several unique characteristics.
GCMB had two mRNA instability motifs in the 3P-UTR like
dgcm and mgcmb, suggesting that GCMB (or mgcmb) is un-
stable in vivo as is dgcm. In addition to the structures common
to all GCMs including the gcm motif and the PEST-like se-
quence, the GCMB deduced protein contained a nuclear tar-
geting sequence and two homopolymeric stretches of proline.
The nuclear targeting sequence was present in dGCM and
mGCMb, but not in hGCMa and mGCMa/1. GCMB exhib-
ited a high degree of homology to mgcmb in terms of both
mRNA and the deduced protein sequence and so did hgcma to
mgcma/1. These ¢ndings indicate that mammals possess a
novel family of gcm motif proteins which consist of at least
two di¡erent gcm isoforms, one with a nuclear targeting se-
quence (B isoform) and the other without (A isoform).
Detection of mgcma/1 and mgcmb transcripts by means of
Northern blot has not been successful and it is con¢ned to the
RT-PCR method. Transcripts of both mgcma/1 and mgcmb
at very low levels were observed in fetal mouse brain (personal
communication in July, 1998 from Drs. T. Hosoya and Y.
Hotta at the National Institute of Genetics, Japan). Although
the expression analysis of mgcma/1 was performed by means
of in situ hybridization, no signi¢cant signal was detectable in
both embryonal and adult brain of mice [16]. As in the case of
mice, detection of GCMB transcripts was limited to use of the
RT-PCR method in our study. In normal tissues, the tran-
scripts were detected in fetal brain and adult kidney. Droso-
phila gcm expression has been reported to be indispensable for
development of not only CNS glia but also larval optic lobe
primordia, adult peripheral nervous system and scavenger lin-
eage cells in post-developmental stages [11,32]. These ¢ndings
suggest that GCMB may be expressed and play certain roles
in various tissues in both developmental and post-develop-
mental stages.
GCMB is likely to be located within chromosome 6p24.2.
These loci have been demonstrated to be linked to a series of
CNS disorders such as schizophrenia and orofacial clefting
[33^35]. This ¢nding suggests a possible correlation of the
GCMB gene with such CNS diseases. Moreover, chromosome
6 has the fourth most frequent abnormalities in human cancer
[36] and a correlation between abnormal chromosome 6 and
some adult or pediatric CNS tumors was previously reported
[37^39]. Several ESTs matching GCMB have recently been
isolated from parathyroid tumor cells. These ¢ndings indicate
a possible correlation between GCMB and human tumor
cells. We therefore screened the expression of the GCMB
transcript in various tumor cells by means of the RT-PCR
method. The GCMB transcript was found to be not limited
to neuroepithelial tumor cells and to be relatively speci¢c to
embryonic or pediatric tumors such as medulloblastoma, ter-
atocarcinoma and transformed embryonic kidney epithelial
cells. In brain and kidney, GCMB transcript was detectable
in both normal and tumor cells. These data suggest that
GCMB may have a certain signi¢cance in these tumors. Sim-
ilarly, we detected hgcma transcripts by means of RT-PCR in
the various lineages of human cell lines (unpublished data).
These ¢ndings may provide some indications for clari¢cation
of the function of human gcm genes.
In conclusion, our study has provided a novel hypothetical
idea that humans have at least two gcm homologues: one
isoform with a nuclear targeting sequence similar to dgcm
and the other without. Although low-level transcripts of
both isoforms were detectable in both the developmental
and post-developmental stages, their exact roles remain to
be identi¢ed.
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